Rigas G Kalaitzidis Selected Research

Rigas G Kalaitzidis Research Topics

Disease

10	Hypertension (High Blood Pressure) 01/2023 - 01/2008
6	Albuminuria 01/2022 - 03/2009
5	Chronic Renal Insufficiency 01/2022 - 01/2011
5	Proteinuria 01/2017 - 03/2009
4	Kidney Diseases (Kidney Disease) 01/2023 - 09/2009
3	Obesity 01/2023 - 09/2011
3	Atherosclerosis 10/2022 - 09/2010
3	COVID-19 01/2022 - 12/2021
2	Cardio-Renal Syndrome 08/2023 - 01/2023
2	Overweight 01/2023 - 09/2011
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2023 - 01/2021
2	Insulin Resistance 01/2023 - 01/2022
2	Heart Failure 01/2022 - 01/2009
2	Disease Progression 01/2022 - 01/2011
2	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 12/2021
2	Stroke (Strokes) 05/2021 - 08/2017
1	Anemia 08/2023
1	Iron Deficiencies 08/2023
1	Type 2 Diabetes Mellitus (MODY) 01/2023
1	Prediabetic State (Prediabetes) 01/2023
1	Weight Loss (Weight Reduction) 01/2023
1	Non-alcoholic Fatty Liver Disease 12/2022
1	Fibrosis (Cirrhosis) 11/2022
1	Fatty Liver 11/2022
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 01/2022
1	Vascular System Injuries 01/2022
1	Hyperglycemia 01/2022
1	Thromboembolism 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Lactic Acidosis 12/2021
1	Myocardial Infarction 05/2021
1	Hypertriglyceridemia 01/2021
1	Dyslipidemias (Dyslipidemia) 01/2021
1	Cognitive Dysfunction 01/2020
1	IGA Glomerulonephritis (IGA Nephropathy) 08/2017
1	Atrial Fibrillation 08/2017
1	Hyperphosphatemia 01/2014
1	Bone Diseases (Bone Disease) 01/2014
1	Prehypertension 02/2010
1	Diabetic Nephropathies (Diabetic Nephropathy) 03/2009

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 01/2023 - 09/2010
4	Antihypertensive Agents (Antihypertensives)IBA 01/2022 - 09/2009
3	CreatinineIBA 01/2022 - 09/2007
2	SodiumIBA 01/2023 - 10/2022
2	trimethyloxamine (trimethylamine N-oxide)IBA 12/2022 - 09/2007
2	Indicators and Reagents (Reagents)IBA 11/2022 - 01/2022
2	Glucose (Dextrose)FDA LinkGeneric 10/2022 - 01/2022
2	SaltsIBA 01/2021 - 10/2016
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 01/2011
2	ReninIBA 07/2015 - 01/2008
2	AlbuminsIBA 07/2015 - 09/2009
2	AngiotensinsIBA 07/2015 - 01/2008
2	C-Reactive ProteinIBA 07/2015 - 01/2009
2	aliskiren FDA Link 12/2014 - 03/2009
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 03/2009 - 01/2008
2	Angiotensin Receptor AntagonistsIBA 03/2009 - 01/2008
1	IronIBA 08/2023
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2023
1	HDL LipoproteinsIBA 01/2023
1	Triglycerides (Triacylglycerol)IBA 01/2023
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 10/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 10/2022
1	SymportersIBA 10/2022
1	LDL Lipoproteins (beta Lipoproteins)IBA 10/2022
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2022
1	MelatoninIBA 01/2022
1	Vitamin D FDA LinkGeneric 01/2022
1	Metformin (Glucophage)FDA LinkGeneric 12/2021
1	SmokeIBA 05/2021
1	Lipoprotein(a)IBA 01/2021
1	Proprotein Convertase 9IBA 01/2021
1	1,4-dihydropyridine (dihydropyridine)IBA 11/2018
1	AnticoagulantsIBA 08/2017
1	Dabigatran FDA Link 08/2017
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2017
1	Fibrinogen (Factor I)FDA Link 07/2015
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 07/2015
1	Sevelamer (RenaGel)FDA Link 01/2014
1	CalciumIBA 01/2014
1	Phosphates (Orthophosphate)IBA 01/2014
1	lanthanum carbonate (Fosrenol)FDA Link 01/2014
1	LeptinIBA 09/2011
1	alpha-2-HS-GlycoproteinIBA 09/2011
1	AdiponectinIBA 09/2011
1	Glycoproteins (Glycoprotein)IBA 03/2009
1	Renin InhibitorsIBA 03/2009
1	GlycosaminoglycansIBA 03/2009
1	glucuronyl glucosamine glycan sulfate (sulodexide)IBA 03/2009
1	LipidsIBA 01/2009
1	ThiazolidinedionesIBA 01/2009

Therapy/Procedure

6	Therapeutics 08/2013 - 03/2009
2	Renal Dialysis (Hemodialysis) 01/2023 - 09/2011
2	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2022 - 01/2021
1	Bariatric Surgery 10/2022
1	Transjugular Intrahepatic Portasystemic Shunt 01/2017
1	Sympathectomy (Sympathectomies) 08/2013
1	Catheters 08/2013
1	Secondary Prevention 01/2011
1	Glycemic Control 09/2010
1	Aftercare (After-Treatment) 11/2009